Total Payments
$229,106
2024 Payments
$10,367
Companies
67
Transactions
1,709
Medicare Patients
624
Medicare Billing
$37,896
Payment Breakdown by Category
Other$162,005 (70.7%)
Travel$37,624 (16.4%)
Food & Beverage$25,650 (11.2%)
Consulting$2,500 (1.1%)
Education$1,327 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $146,130 | 75 | 63.8% |
| Travel and Lodging | $37,624 | 175 | 16.4% |
| Food and Beverage | $25,650 | 1,359 | 11.2% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $15,875 | 7 | 6.9% |
| Consulting Fee | $2,500 | 1 | 1.1% |
| Education | $1,327 | 92 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AMAG Pharmaceuticals, Inc. | $120,243 | 341 | $0 (2019) |
| Astellas Pharma US Inc | $31,812 | 125 | $0 (2024) |
| PFIZER INC. | $16,260 | 238 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $12,138 | 22 | $0 (2017) |
| ABBVIE INC. | $10,248 | 108 | $0 (2024) |
| Shionogi Inc | $9,379 | 15 | $0 (2017) |
| Myovant Sciences Inc. | $7,629 | 25 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $4,003 | 10 | $0 (2020) |
| TherapeuticsMD, Inc. | $3,900 | 56 | $0 (2022) |
| Amgen Inc. | $1,874 | 104 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $10,367 | 124 | Astellas Pharma US Inc ($8,373) |
| 2023 | $36,128 | 192 | Astellas Pharma US Inc ($22,571) |
| 2022 | $20,146 | 194 | ABBVIE INC. ($8,861) |
| 2021 | $5,185 | 166 | PFIZER INC. ($2,787) |
| 2020 | $2,047 | 153 | Radius Health, Inc. ($259.41) |
| 2019 | $11,513 | 222 | AMAG Pharmaceuticals, Inc. ($5,903) |
| 2018 | $102,415 | 396 | AMAG Pharmaceuticals, Inc. ($100,838) |
| 2017 | $41,305 | 262 | AMAG Pharmaceuticals, Inc. ($13,501) |
All Payment Transactions
1,709 individual payment records from CMS Open Payments — Page 1 of 69
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $10.30 | General |
| Category: HORMONE THERAPY | ||||||
| 12/18/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $3.45 | General |
| Category: HORMONE THERAPY | ||||||
| 12/17/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: PAIN | ||||||
| 12/17/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $3.12 | General |
| Category: Bone Health | ||||||
| 12/11/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/09/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $8.81 | General |
| Category: UROLOGY | ||||||
| 12/04/2024 | Astellas Pharma US Inc | Veozah (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: Biological | ||||||
| 12/04/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $91.75 | General |
| Category: Biological | ||||||
| 12/04/2024 | PFIZER INC. | PREMARIN (Drug), DUAVEE, MYFEMBREE | Food and Beverage | In-kind items and services | $11.88 | General |
| Category: WOMENS HEALTH | ||||||
| 11/25/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: Bone Health | ||||||
| 11/21/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $8.15 | General |
| 11/20/2024 | Astellas Pharma US Inc | Veozah (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: Biological | ||||||
| 11/20/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $124.89 | General |
| Category: Biological | ||||||
| 11/20/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: Obesity | ||||||
| 11/20/2024 | Astellas Pharma US Inc | Veozah (Drug) | Travel and Lodging | Cash or cash equivalent | $17.82 | General |
| Category: Biological | ||||||
| 11/19/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $7.80 | General |
| Category: UROLOGY | ||||||
| 11/12/2024 | PFIZER INC. | PREMARIN (Drug), DUAVEE, MYFEMBREE | Food and Beverage | In-kind items and services | $5.00 | General |
| Category: WOMENS HEALTH | ||||||
| 10/31/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $2.31 | General |
| Category: Bone Health | ||||||
| 10/30/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: HORMONE THERAPY | ||||||
| 10/30/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $1.38 | General |
| Category: HORMONE THERAPY | ||||||
| 10/29/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $19.53 | General |
| 10/23/2024 | PFIZER INC. | PREMARIN (Drug), DUAVEE, MYFEMBREE | Food and Beverage | In-kind items and services | $2.82 | General |
| Category: WOMENS HEALTH | ||||||
| 10/22/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $7.49 | General |
| Category: UROLOGY | ||||||
| 10/21/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Biological | ||||||
| 10/16/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | Cash or cash equivalent | $124.99 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 149 | 167 | $14,992 | $9,370 |
| 2022 | 3 | 170 | 188 | $15,955 | $10,065 |
| 2021 | 3 | 164 | 180 | $14,874 | $9,507 |
| 2020 | 4 | 141 | 166 | $15,498 | $8,954 |
Total Patients
624
Total Services
701
Medicare Billing
$37,896
Procedure Codes
13
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 43 | 61 | $8,845 | $5,284 | 59.7% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 71 | 71 | $4,047 | $2,643 | 65.3% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 35 | 35 | $2,100 | $1,443 | 68.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 40 | 58 | $8,410 | $4,949 | 58.8% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 85 | 85 | $4,845 | $3,233 | 66.7% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 45 | 45 | $2,700 | $1,882 | 69.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 35 | 51 | $7,395 | $4,402 | 59.5% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 87 | 87 | $4,959 | $3,329 | 67.1% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 42 | 42 | $2,520 | $1,776 | 70.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 36 | 59 | $8,555 | $4,404 | 51.5% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 60 | 60 | $3,420 | $2,320 | 67.8% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2020 | 28 | 28 | $1,680 | $1,166 | 69.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 17 | 19 | $1,843 | $1,064 | 57.7% |
About Dr. Diane Sutter, MD
Dr. Diane Sutter, MD is a Gynecology healthcare provider based in Kenmore, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1447291703.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Diane Sutter, MD has received a total of $229,106 in payments from pharmaceutical and medical device companies, with $10,367 received in 2024. These payments were reported across 1,709 transactions from 67 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($146,130).
As a Medicare-enrolled provider, Sutter has provided services to 624 Medicare beneficiaries, totaling 701 services with total Medicare billing of $37,896. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Ad
Practice Information
- Specialty Gynecology
- Location Kenmore, NY
- Active Since 06/09/2006
- Last Updated 11/05/2014
- Taxonomy Code 207VG0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1447291703
Products in Payments
- INTRAROSA (Drug) $120,224
- Veozah (Drug) $30,483
- MYFEMBREE (Drug) $14,009
- ADDYI (Drug) $12,138
- Osphena (Drug) $9,392
- NURTEC ODT (Drug) $8,513
- ORILISSA (Drug) $5,600
- PARAGARD (Drug) $3,961
- ORIAHNN (Drug) $3,170
- BIJUVA (Drug) $1,827
- IMVEXXY (Drug) $1,806
- Saxenda (Drug) $860.70
- EVENITY (Biological) $851.74
- PREMARIN (Drug) $728.17
- Prolia (Biological) $706.69
- Auvelity (Drug) $544.76
- UBRELVY (Drug) $537.26
- Tymlos (Biological) $498.65
- Vascepa (Drug) $425.15
- PREMARIN ORALS (Drug) $423.08
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.